New pill aims to tame Narcolepsy's sudden collapses and crushing fatigue
NCT ID NCT05059223
First seen Jun 02, 2026 · Last updated Jun 10, 2026 · Updated 2 times
Summary
This study tested an investigational drug called AXS-12 in 90 people with narcolepsy who experience cataplexy (sudden muscle weakness) and excessive daytime sleepiness. The goal was to see if the drug could safely reduce the number of cataplexy attacks and improve alertness compared to a placebo. The trial was completed and results will show whether AXS-12 offers a new treatment option for these challenging symptoms.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NARCOLEPSY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Clinical Research Site
Alabaster, Alabama, 35007, United States
-
Clinical Research Site
Peoria, Arizona, 85381, United States
-
Clinical Research Site
Phoenix, Arizona, 85054, United States
-
Clinical Research Site
Redwood City, California, 94063, United States
-
Clinical Research Site
San Diego, California, 92103, United States
-
Clinical Research Site
Santa Ana, California, 92705, United States
-
Clinical Research Site
Santa Monica, California, 90404, United States
-
Clinical Research Site
Boulder, Colorado, 80301, United States
-
Clinical Research Site
Colorado Springs, Colorado, 80918, United States
-
Clinical Research Site
Brandon, Florida, 33511, United States
-
Clinical Research Site
Clearwater, Florida, 33765, United States
-
Clinical Research Site
Doral, Florida, 33122, United States
-
Clinical Research Site
Kissimmee, Florida, 34741, United States
-
Clinical Research Site
Miami, Florida, 33176, United States
-
Clinical Research Site
Miami Lakes, Florida, 33016, United States
-
Clinical Research Site
St. Petersburg, Florida, 33707, United States
-
Clinical Research Site
Tampa, Florida, 33634, United States
-
Clinical Research Site
Winter Park, Florida, 32789, United States
-
Clinical Research Site
Atlanta, Georgia, 30315, United States
-
Clinical Research Site
Atlanta, Georgia, 30328, United States
-
Clinical Research Site
Gainesville, Georgia, 30501, United States
-
Clinical Research Site
Macon, Georgia, 31210, United States
-
Clinical Research Site
Stockbridge, Georgia, 30281, United States
-
Clinical Research Site
Honolulu, Hawaii, 96817, United States
-
Clinical Research Site
Peoria, Illinois, 61637, United States
-
Clinical Research Site
Fort Wayne, Indiana, 46804, United States
-
Clinical Research Site
Chevy Chase, Maryland, 20815, United States
-
Clinical Research Site
Newton, Massachusetts, 02459, United States
-
Clinical Research Site
North Dartmouth, Massachusetts, 02747, United States
-
Clinical Research Site
Kalamazoo, Michigan, 49008, United States
-
Clinical Research Site
Novi, Michigan, 48377, United States
-
Clinical Research Site
St Louis, Missouri, 63123, United States
-
Clinical Research Site
Las Vegas, Nevada, 89106, United States
-
Clinical Research Site
Neptune City, New Jersey, 07753, United States
-
Clinical Research Site
Brooklyn, New York, 11230, United States
-
Clinical Research Site
New Hyde Park, New York, 11040, United States
-
Clinical Research Site
Denver, North Carolina, 28037, United States
-
Clinical Research Site
Gastonia, North Carolina, 28054, United States
-
Clinical Research Site
Huntersville, North Carolina, 28078, United States
-
Clinical Research Site
Cincinnati, Ohio, 45245, United States
-
Clinical Research Site
Wyomissing, Pennsylvania, 19610, United States
-
Clinical Research Site
Charleston, South Carolina, 29425, United States
-
Clinical Research Site
Columbia, South Carolina, 29201, United States
-
Clinical Research Site
Austin, Texas, 78731, United States
-
Clinical Research Site
San Antonio, Texas, 78229, United States
-
Clinical Research Site
Sugar Land, Texas, 77478, United States
-
Clinical Research Site
Williamsburg, Virginia, 23188, United States
-
Clinical Research Site
Markham, Ontario, L3R 1A3, Canada
-
Clinical Research Site
Toronto, Ontario, M4P 1P2, Canada
-
Clinical Research Site
Toronto, Ontario, M5S 3A3, Canada
Conditions
Explore the condition pages connected to this study.